Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,429,600 | 2,964,500 | 2,268,000 | 2,825,000 | 2,315,000 |
| Marketable Securities | 39,700 | 34,900 | 28,900 | 26,800 | 47,800 |
| Receivables | 1,473,000 | 1,409,300 | 1,437,100 | 1,372,200 | 1,345,200 |
| Inventories | 803,900 | 775,700 | 729,000 | 577,700 | 586,800 |
| TOTAL | $6,452,600 | $5,833,000 | $5,067,800 | $5,367,900 | $4,870,200 |
| Non-Current Assets | |||||
| PPE Net | 1,244,800 | 1,238,800 | 1,214,500 | 1,196,400 | 1,159,900 |
| Intangibles | 8,148,400 | 8,102,500 | 8,157,300 | 7,134,900 | 9,259,700 |
| Other Non-Current Assets | 2,804,400 | 2,928,700 | 3,108,800 | 3,004,000 | 2,858,700 |
| TOTAL | $12,197,600 | $12,270,000 | $12,480,600 | $11,335,300 | $13,278,300 |
| Total Assets | $18,650,200 | $18,103,000 | $17,548,400 | $16,703,200 | $18,148,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 143,200 | 142,400 | 138,600 | 126,800 | 126,700 |
| Accounts payable and accrued liabilities | 125,300 | 118,600 | 89,200 | 861,600 | 862,800 |
| Accrued Expenses | 910,700 | 1,084,700 | 978,400 | N/A | N/A |
| Other current liabilities | 247,000 | 279,000 | 124,800 | 131,700 | 130,400 |
| TOTAL | $1,426,200 | $1,624,700 | $1,331,000 | $1,120,100 | $1,119,900 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,388,800 | 2,419,600 | 2,453,300 | 2,311,600 | 2,343,300 |
| Other Non-Current Liabilities | 911,900 | 775,300 | 871,000 | 833,900 | 824,200 |
| TOTAL | $4,793,000 | $4,827,100 | $5,142,500 | $5,092,300 | $5,280,800 |
| Total Liabilities | $6,219,200 | $6,451,800 | $6,473,500 | $6,212,400 | $6,400,700 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 221,019 | 219,712 | 218,845 | 219,173 | 220,827 |
| Retained earnings | 5,879,200 | 5,243,200 | 4,707,400 | 4,129,300 | 5,197,400 |
| Other shareholders' equity | -70,500 | -124,900 | -118,900 | -110,900 | -101,500 |
| TOTAL | $12,431,000 | $11,651,200 | $11,074,900 | $10,490,800 | $11,747,800 |
| Total Liabilities And Equity | $18,650,200 | $18,103,000 | $17,548,400 | $16,703,200 | $18,148,500 |